Updated: January 15, 2026
Why Is Miebo So Hard to Find? [Explained for 2026]
Author
Peter Daggett

Summarize with AI
- What Is Miebo and Why Does It Matter?
- Why Is Miebo Sometimes Hard to Find at Pharmacies?
- 1. Miebo Is Brand-Only — No Generic Available
- 2. It's a Newer Drug — Not Yet in Every Pharmacy's Standard Formulary
- 3. High Cost Creates a Chicken-and-Egg Stocking Problem
- 4. Insurance Prior Authorization Delays
- 5. Specialty Distribution Through BlinkRx
- What Should You Do If You Can't Find Miebo?
- Is Miebo in an Official Shortage?
- What If I Still Can't Get Miebo Filled?
- The Bottom Line
Miebo is a brand-only dry eye drug with no generic. Learn why some pharmacies don't stock it and what you can do to find it near you.
If you have a Miebo prescription and keep running into empty shelves — or pharmacists who've never even heard of it — you're not imagining things. Miebo (perfluorohexyloctane) is a relatively new, brand-only dry eye medication that not every pharmacy stocks routinely. In this article, we'll explain exactly why Miebo can be hard to find and walk you through actionable steps to get your prescription filled.
What Is Miebo and Why Does It Matter?
Miebo is the brand name for perfluorohexyloctane ophthalmic solution, FDA-approved in May 2023. It was developed by Novaliq and is now sold in the United States by Bausch + Lomb. What makes Miebo unique is its mechanism of action: rather than increasing tear production like most dry eye drugs, Miebo forms a thin, protective monolayer on the surface of the tear film that physically slows tear evaporation.
This makes it the first and only FDA-approved prescription eye drop that directly targets tear evaporation — the leading cause of dry eye in about 9 out of 10 sufferers. It's a meaningful step forward for patients with evaporative dry eye linked to meibomian gland dysfunction (MGD), a condition in which the oil glands in the eyelids don't produce enough of the lipid layer that normally protects tears.
Why Is Miebo Sometimes Hard to Find at Pharmacies?
Miebo is not on the FDA's official drug shortage list, so the availability issue isn't a shortage in the traditional sense. Instead, several factors combine to make Miebo inconsistently available:
1. Miebo Is Brand-Only — No Generic Available
As of 2026, there is no FDA-approved generic version of Miebo. That means every prescription must be filled with the brand-name product, which retails for $800 to over $1,200 for a 3 mL bottle (a 30-day supply). Not all pharmacies choose to stock expensive brand-name-only medications, especially if local demand is low.
2. It's a Newer Drug — Not Yet in Every Pharmacy's Standard Formulary
Miebo was approved in May 2023 and became widely commercially available later that year. While it gained strong formulary coverage quickly — about 75% of commercial plans and 65% of Medicare Part D plans cover it as of January 2025 — some smaller retail pharmacies have been slower to add it to their standard inventory. Newer specialty ophthalmic medications often take time to get into the full distribution pipeline.
3. High Cost Creates a Chicken-and-Egg Stocking Problem
Pharmacies generally order medications based on historical demand. If a pharmacy hasn't dispensed many Miebo prescriptions, it may not stock it — which means patients who show up with a new Miebo prescription are told to come back in a few days while the pharmacy orders it. This creates a frustrating cycle for patients, especially those trying Miebo for the first time.
4. Insurance Prior Authorization Delays
Even when Miebo is in stock, some insurance plans require prior authorization (PA) before they'll cover it. If your pharmacy submits the claim and hits a PA wall, your prescription can sit in limbo while the authorization is processed — sometimes taking several business days. This can feel like the medication is unavailable when the real issue is administrative.
5. Specialty Distribution Through BlinkRx
Bausch + Lomb has partnered with the digital pharmacy BlinkRx to distribute Miebo nationally via mail delivery. This is a legitimate, widely-used channel for Miebo prescriptions — but it means some retail pharmacies intentionally stock less, since the manufacturer routes many prescriptions through BlinkRx. If your prescriber e-prescribes to BlinkRx, you may never need to check retail pharmacies at all.
What Should You Do If You Can't Find Miebo?
Here are your best options if you're having trouble filling your Miebo prescription:
- Use medfinder to find pharmacies near you that currently have Miebo in stock, without spending hours on the phone.
- Ask your eye doctor to e-prescribe to BlinkRx — Bausch + Lomb's preferred delivery pharmacy. BlinkRx will text you within 15 minutes and can handle prior authorization and free delivery.
- Try independent pharmacies in your area. They often stock specialty ophthalmic medications and can sometimes order Miebo faster than large chains.
- Call ahead and ask specifically for "Miebo" or "perfluorohexyloctane ophthalmic solution." This helps the pharmacy staff identify it by both brand and generic name.
- If your insurance requires prior authorization and the process is stalled, ask your prescriber to contact the insurer directly or use an electronic PA platform.
Is Miebo in an Official Shortage?
No. As of 2026, Miebo is not listed on the FDA's drug shortage database. The access challenges patients experience are not due to a manufacturing shortage, but rather to the drug's novelty, high price, brand-only status, and distribution patterns. Bausch + Lomb produced $172 million in Miebo sales in 2024 alone — production is robust. The issue is getting the drug from manufacturer to patient efficiently.
What If I Still Can't Get Miebo Filled?
If all else fails, talk to your eye doctor about alternatives. Several FDA-approved dry eye medications work through different mechanisms and may be more readily available at local pharmacies. Options include Xiidra (lifitegrast), Restasis or generic cyclosporine, Cequa, Vevye, and Tyrvaya (a nasal spray). Each has a different mechanism, side effect profile, and cost structure. For a full comparison, see our guide on
If all else fails, talk to your eye doctor about alternatives. Several FDA-approved dry eye medications work through different mechanisms and may be more readily available at local pharmacies. Options include Xiidra (lifitegrast), Restasis or generic cyclosporine, Cequa, Vevye, and Tyrvaya (a nasal spray). For a full comparison, see our guide on alternatives to Miebo.
The Bottom Line
Miebo is not in a shortage — but finding it at a specific retail pharmacy can require some legwork. The fastest routes are BlinkRx mail delivery or using medfinder to check which local pharmacies currently have it on the shelf. Don't let logistics stand between you and effective dry eye relief.
Frequently Asked Questions
No. Miebo (perfluorohexyloctane) is not on the FDA's official drug shortage list in 2026. Some patients have difficulty finding it at retail pharmacies because it is a brand-only drug with no generic, and not all pharmacies stock it routinely. BlinkRx mail delivery and tools like medfinder can help you locate it.
Pharmacies typically stock medications based on local demand history. Because Miebo is newer (FDA-approved in May 2023) and brand-only — with no generic and a retail price over $800 — some pharmacies choose not to stock it unless they have regular demand. Ask your pharmacist to special-order it, or use medfinder to find a pharmacy that already has it in stock.
Yes. Bausch + Lomb has partnered with BlinkRx, a digital pharmacy that delivers Miebo nationally with free shipping. Your prescriber can e-prescribe directly to BlinkRx, and the pharmacy will text you within about 15 minutes. BlinkRx can also assist with prior authorization if your insurance requires it.
The retail cash price for Miebo is approximately $800 to $1,200 for a 3 mL bottle (a 30-day supply). With a discount card through GoodRx, you may pay around $778. There is no generic version available, so there is no lower-cost alternative to the brand.
Most insurance plans do cover Miebo. As of January 2025, about 75% of commercial insurance plans, about 65% of Medicare Part D plans, and almost all Medicaid plans cover Miebo. Prior authorization may be required by some plans. Eligible commercially insured patients may pay as little as $0 using the MIEBO MySavings copay card.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Miebo also looked for:
More about Miebo
31,889 have already found their meds with Medfinder.
Start your search today.





